Fruth Investment Management Has $527,000 Holdings in Corteva (NYSE:CTVA)

Fruth Investment Management lifted its position in shares of Corteva (NYSE:CTVA) by 75.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,853 shares of the company’s stock after purchasing an additional 8,121 shares during the quarter. Fruth Investment Management’s holdings in Corteva were worth $527,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in CTVA. Bedel Financial Consulting Inc. boosted its stake in Corteva by 24.6% in the 3rd quarter. Bedel Financial Consulting Inc. now owns 5,082 shares of the company’s stock valued at $142,000 after buying an additional 1,004 shares in the last quarter. Pennsylvania Trust Co acquired a new stake in Corteva in the 3rd quarter valued at $4,315,000. Nachman Norwood & Parrott Inc boosted its stake in Corteva by 5.2% in the 3rd quarter. Nachman Norwood & Parrott Inc now owns 14,691 shares of the company’s stock valued at $412,000 after buying an additional 724 shares in the last quarter. Everence Capital Management Inc. acquired a new stake in Corteva in the 3rd quarter valued at $410,000. Finally, Carroll Financial Associates Inc. acquired a new stake in Corteva in the 3rd quarter valued at $558,000. 72.17% of the stock is currently owned by institutional investors.

NYSE CTVA traded down $0.05 on Wednesday, reaching $26.17. The company had a trading volume of 3,916,655 shares, compared to its average volume of 5,843,840. The company has a 50 day moving average of $28.62. Corteva has a 52 week low of $24.35 and a 52 week high of $32.78.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.43. The company had revenue of $5.56 billion during the quarter, compared to the consensus estimate of $5.47 billion. The company’s revenue was down 3.1% compared to the same quarter last year. On average, equities research analysts predict that Corteva will post 1.17 EPS for the current year.

A number of equities analysts have commented on the company. JPMorgan Chase & Co. assumed coverage on Corteva in a research note on Friday, June 21st. They issued an “overweight” rating and a $30.00 price objective on the stock. Royal Bank of Canada raised Corteva from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $29.00 to $38.00 in a research note on Friday, August 9th. Loop Capital assumed coverage on Corteva in a research note on Monday, July 1st. They issued a “hold” rating and a $31.00 price objective on the stock. Deutsche Bank boosted their price objective on Corteva from $32.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd. Finally, Argus assumed coverage on Corteva in a research note on Thursday, June 20th. They issued a “hold” rating on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $32.00.

In other news, insider Timothy P. Glenn acquired 6,500 shares of Corteva stock in a transaction dated Monday, August 5th. The stock was bought at an average cost of $30.52 per share, with a total value of $198,380.00. Also, Director Klaus A. Engel acquired 18,393 shares of Corteva stock in a transaction dated Friday, August 30th. The shares were purchased at an average cost of $30.00 per share, with a total value of $551,790.00. Following the completion of the transaction, the director now directly owns 25,253 shares of the company’s stock, valued at $757,590. The disclosure for this purchase can be found here.

Corteva Company Profile

Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.

Featured Story: Balance Sheet

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.